In persons at intermediate risk for CVD, polypills reduce a composite of CV events at 5 y
- PMID: 34978850
- DOI: 10.7326/J21-0004
In persons at intermediate risk for CVD, polypills reduce a composite of CV events at 5 y
Abstract
Joseph P, Roshandel G, Gao P, et al. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis. Lancet. 2021;398:1133-46. 34469765.
Comment on
-
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis.Lancet. 2021 Sep 25;398(10306):1133-1146. doi: 10.1016/S0140-6736(21)01827-4. Epub 2021 Aug 29. Lancet. 2021. PMID: 34469765
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources